+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Ambulatory Polysomnography Systems Market By Product, By Application, By End-user: Global Opportunity Analysis and Industry Forecast, 2022-2031

  • PDF Icon

    Report

  • 280 Pages
  • May 2023
  • Region: Global
  • Allied Market Research
  • ID: 5879144
UP TO OFF until Oct 24th 2024
The global ambulatory polysomnography systems market is envisioned to garner $570.7 million by 2031, growing from $327.0 million in 2021 at a CAGR of 6.0% from 2022 to 2031.

Ambulatory polysomnography (Amb-PSG), also known as type II PSG, can be used to identify different sleep disorders by characterizing sleep stages and quantifying arousals, total sleep time (TST), and an accurate respiratory disturbance index (RDI). Ambulatory polysomnography systems are in high demand among patients suffering from a variety of sleep disorders due to the benefits they provide. This is propelling the ambulatory polysomnography systems market.

The majority of the population, particularly in rural regions, is uninformed of the dangers of sleep apnea. Sleep disorders that go untreated can lead to chronic ailments like heart failure, stroke, high blood pressure, diabetes, and obesity. This can result in major health issues such as uncontrolled blood pressure, heart attacks, weakened and restricted blood vessels in the kidneys, and aneurysms. The population's lack of awareness about sleeping difficulties is expected to stymie the growth of the ambulatory polysomnography systems market in the near future.

Technological improvements in the sleep care business can be identified as a driving force in this market. The ambulatory polysomnography systems market is growing steadily due to numerous revolutionary technologies such as portable devices, smartphone applications, telemedicine, and so on. Wireless and portable polysomnography systems, like as Nox Medical's Nox A1s PSG, have benefited from research and development. Wireless capabilities give patients with a sense of liberty by allowing them freedom of movement while they are being diagnosed. This will have a beneficial impact on the growth of the ambulatory polysomnography systems market.

The global market has benefited by the outbreak of the COVID-19 pandemic. Key participants claimed considerable revenue growth as a result of an Increase in the number of patients suffering from sleep difficulties as a result of the COVID19 pandemic. According to the poll, 70% of respondents have experienced one or more new sleep issues Ince the start of the COVID-19, leading to an Increase in the use of sleep apnea equipment. As a result of this, the PSG systems’ businesses launched a clinically certified, low-touch CPAP Mask Selector tool that can be utilized remotely from the patient's home.

The key players profiled in this report Include Koninklijke Philips N.V., Natus Medical Incorporated, Nihon Kohden Corporation, Nox Medical, Löwenstein Medical Technology GmbH + Co. KG., neurosoft, Cadwell Industries Inc., SOMNOmedics GmbH, Compumedics Limited, and Neurovirtual / Sleepvirtual.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ambulatory polysomnography (psg) systems market analysis from 2021 to 2031 to identify the prevailing ambulatory polysomnography (psg) systems market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the ambulatory polysomnography (psg) systems market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report Includes the analysis of the regional as well as global ambulatory polysomnography (psg) systems market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Up to 12 Channel PSG Systems
  • Up to 24 Channel PSG Systems
  • Up to 32 Channel PSG Systems
  • Above 32 Channel PSG Systems

By Application

  • Obstructive Sleep
  • Apnea Narcolepsy
  • Chronic Insomnia
  • Others

By End-User

  • Hospitals
  • Sleep Laboratories
  • Home Care Settings

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • United Arab Emirates
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Cadwell Industries Inc.
  • Compumedics Limited
  • Compumedics Limited
  • Koninklijke Philips N.V.
  • Löwenstein Medical Technology GmbH + Co. KG.
  • Natus Medical Incorporated
  • neurosoft
  • Nihon Kohden Corporation
  • Nox Medical
  • SOMNOmedics GmbH

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
3.6. Average Selling Price
3.7. Brand Share Analysis
3.8. Key Regulation Analysis
3.9. Market Share Analysis
3.10. Patent Landscape
3.11. Regulatory Guidelines
3.12. Value Chain Analysis
CHAPTER 4: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Up to 12 Channel PSG Systems
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Up to 24 Channel PSG Systems
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Up to 32 Channel PSG Systems
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Above 32 Channel PSG Systems
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Obstructive Sleep
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Apnea Narcolepsy
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Chronic Insomnia
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Sleep Laboratories
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Home Care Settings
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Product
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End-user
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Product
7.2.5.1.3. Market size and forecast, by Application
7.2.5.1.4. Market size and forecast, by End-user
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Product
7.2.5.2.3. Market size and forecast, by Application
7.2.5.2.4. Market size and forecast, by End-user
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Product
7.2.5.3.3. Market size and forecast, by Application
7.2.5.3.4. Market size and forecast, by End-user
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Product
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End-user
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Product
7.3.5.1.3. Market size and forecast, by Application
7.3.5.1.4. Market size and forecast, by End-user
7.3.5.2. UK
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Product
7.3.5.2.3. Market size and forecast, by Application
7.3.5.2.4. Market size and forecast, by End-user
7.3.5.3. France
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Product
7.3.5.3.3. Market size and forecast, by Application
7.3.5.3.4. Market size and forecast, by End-user
7.3.5.4. Spain
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Product
7.3.5.4.3. Market size and forecast, by Application
7.3.5.4.4. Market size and forecast, by End-user
7.3.5.5. Italy
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Product
7.3.5.5.3. Market size and forecast, by Application
7.3.5.5.4. Market size and forecast, by End-user
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Product
7.3.5.6.3. Market size and forecast, by Application
7.3.5.6.4. Market size and forecast, by End-user
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Product
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End-user
7.4.5. Market size and forecast, by country
7.4.5.1. China
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Product
7.4.5.1.3. Market size and forecast, by Application
7.4.5.1.4. Market size and forecast, by End-user
7.4.5.2. Japan
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Product
7.4.5.2.3. Market size and forecast, by Application
7.4.5.2.4. Market size and forecast, by End-user
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Product
7.4.5.3.3. Market size and forecast, by Application
7.4.5.3.4. Market size and forecast, by End-user
7.4.5.4. South Korea
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Product
7.4.5.4.3. Market size and forecast, by Application
7.4.5.4.4. Market size and forecast, by End-user
7.4.5.5. Australia
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Product
7.4.5.5.3. Market size and forecast, by Application
7.4.5.5.4. Market size and forecast, by End-user
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Product
7.4.5.6.3. Market size and forecast, by Application
7.4.5.6.4. Market size and forecast, by End-user
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Product
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End-user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Product
7.5.5.1.3. Market size and forecast, by Application
7.5.5.1.4. Market size and forecast, by End-user
7.5.5.2. United Arab Emirates
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Product
7.5.5.2.3. Market size and forecast, by Application
7.5.5.2.4. Market size and forecast, by End-user
7.5.5.3. Saudi Arabia
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Product
7.5.5.3.3. Market size and forecast, by Application
7.5.5.3.4. Market size and forecast, by End-user
7.5.5.4. South Africa
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Product
7.5.5.4.3. Market size and forecast, by Application
7.5.5.4.4. Market size and forecast, by End-user
7.5.5.5. Rest of LAMEA
7.5.5.5.1. Key market trends, growth factors and opportunities
7.5.5.5.2. Market size and forecast, by Product
7.5.5.5.3. Market size and forecast, by Application
7.5.5.5.4. Market size and forecast, by End-user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Koninklijke Philips N.V.
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.2. Natus Medical Incorporated
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.3. Nihon Kohden Corporation
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.4. Nox Medical
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.5. Löwenstein Medical Technology GmbH + Co. KG.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.6. neurosoft
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.7. Cadwell Industries Inc.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.8. SOMNOmedics GmbH
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.9. Compumedics Limited
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.10. Compumedics Limited
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
List of Tables
TABLE 01. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 02. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 12 CHANNEL PSG SYSTEMS, BY REGION, 2021-2031 ($MILLION)
TABLE 03. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 24 CHANNEL PSG SYSTEMS, BY REGION, 2021-2031 ($MILLION)
TABLE 04. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 32 CHANNEL PSG SYSTEMS, BY REGION, 2021-2031 ($MILLION)
TABLE 05. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR ABOVE 32 CHANNEL PSG SYSTEMS, BY REGION, 2021-2031 ($MILLION)
TABLE 06. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 07. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR OBSTRUCTIVE SLEEP, BY REGION, 2021-2031 ($MILLION)
TABLE 08. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR APNEA NARCOLEPSY, BY REGION, 2021-2031 ($MILLION)
TABLE 09. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR CHRONIC INSOMNIA, BY REGION, 2021-2031 ($MILLION)
TABLE 10. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 11. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 12. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR SLEEP LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 14. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR HOME CARE SETTINGS, BY REGION, 2021-2031 ($MILLION)
TABLE 15. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 16. NORTH AMERICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 17. NORTH AMERICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 18. NORTH AMERICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 19. NORTH AMERICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 20. U.S. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 21. U.S. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 22. U.S. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 23. CANADA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 24. CANADA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 25. CANADA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 26. MEXICO AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 27. MEXICO AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 28. MEXICO AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 29. EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 30. EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 31. EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 32. EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 33. GERMANY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 34. GERMANY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 35. GERMANY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 36. UK AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 37. UK AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 38. UK AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 39. FRANCE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 40. FRANCE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 41. FRANCE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 42. SPAIN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 43. SPAIN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 44. SPAIN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 45. ITALY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 46. ITALY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 47. ITALY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 48. REST OF EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 49. REST OF EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 50. REST OF EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 51. ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 52. ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 53. ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 54. ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 55. CHINA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 56. CHINA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 57. CHINA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 58. JAPAN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 59. JAPAN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 60. JAPAN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 61. INDIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 62. INDIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 63. INDIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 64. SOUTH KOREA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 65. SOUTH KOREA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 66. SOUTH KOREA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 67. AUSTRALIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 68. AUSTRALIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 69. AUSTRALIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 73. LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 74. LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 75. LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 76. LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 77. BRAZIL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 78. BRAZIL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 79. BRAZIL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 80. UNITED ARAB EMIRATES AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 81. UNITED ARAB EMIRATES AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 82. UNITED ARAB EMIRATES AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 83. SAUDI ARABIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 84. SAUDI ARABIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 85. SAUDI ARABIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 86. SOUTH AFRICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 87. SOUTH AFRICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 88. SOUTH AFRICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 89. REST OF LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 90. REST OF LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 91. REST OF LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 92. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
TABLE 93. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 94. NATUS MEDICAL INCORPORATED: KEY EXECUTIVES
TABLE 95. NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
TABLE 96. NIHON KOHDEN CORPORATION: KEY EXECUTIVES
TABLE 97. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
TABLE 98. NOX MEDICAL: KEY EXECUTIVES
TABLE 99. NOX MEDICAL: COMPANY SNAPSHOT
TABLE 100. LÖWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG.: KEY EXECUTIVES
TABLE 101. LÖWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG.: COMPANY SNAPSHOT
TABLE 102. NEUROSOFT: KEY EXECUTIVES
TABLE 103. NEUROSOFT: COMPANY SNAPSHOT
TABLE 104. CADWELL INDUSTRIES INC.: KEY EXECUTIVES
TABLE 105. CADWELL INDUSTRIES INC.: COMPANY SNAPSHOT
TABLE 106. SOMNOMEDICS GMBH: KEY EXECUTIVES
TABLE 107. SOMNOMEDICS GMBH: COMPANY SNAPSHOT
TABLE 108. COMPUMEDICS LIMITED: KEY EXECUTIVES
TABLE 109. COMPUMEDICS LIMITED: COMPANY SNAPSHOT
TABLE 110. COMPUMEDICS LIMITED: KEY EXECUTIVES
TABLE 111. COMPUMEDICS LIMITED: COMPANY SNAPSHOT
List of Figures
FIGURE 01. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031
FIGURE 02. SEGMENTATION OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031
FIGURE 03. TOP INVESTMENT POCKETS IN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET (2022-2031)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALAMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
FIGURE 10. IMPACT OF KEY REGULATION: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
FIGURE 11. MARKET SHARE ANALYSIS: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
FIGURE 12. PATENT ANALYSIS BY COMPANY
FIGURE 13. PATENT ANALYSIS BY COUNTRY
FIGURE 14. REGULATORY GUIDELINES: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
FIGURE 15. VALUE CHAIN ANALYSIS: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
FIGURE 16. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 12 CHANNEL PSG SYSTEMS, BY COUNTRY 2021 AND 2031(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 24 CHANNEL PSG SYSTEMS, BY COUNTRY 2021 AND 2031(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 32 CHANNEL PSG SYSTEMS, BY COUNTRY 2021 AND 2031(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR ABOVE 32 CHANNEL PSG SYSTEMS, BY COUNTRY 2021 AND 2031(%)
FIGURE 21. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR OBSTRUCTIVE SLEEP, BY COUNTRY 2021 AND 2031(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR APNEA NARCOLEPSY, BY COUNTRY 2021 AND 2031(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR CHRONIC INSOMNIA, BY COUNTRY 2021 AND 2031(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 26. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021(%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR HOSPITALS, BY COUNTRY 2021 AND 2031(%)
FIGURE 28. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR SLEEP LABORATORIES, BY COUNTRY 2021 AND 2031(%)
FIGURE 29. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR HOME CARE SETTINGS, BY COUNTRY 2021 AND 2031(%)
FIGURE 30. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET BY REGION, 2021
FIGURE 31. U.S. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 32. CANADA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 33. MEXICO AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 34. GERMANY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 35. UK AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 36. FRANCE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 37. SPAIN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 38. ITALY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 39. REST OF EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 40. CHINA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 41. JAPAN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 42. INDIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 43. SOUTH KOREA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 44. AUSTRALIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 45. REST OF ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 46. BRAZIL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 47. UNITED ARAB EMIRATES AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 48. SAUDI ARABIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 49. SOUTH AFRICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 50. REST OF LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
FIGURE 51. TOP WINNING STRATEGIES, BY YEAR
FIGURE 52. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 53. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 54. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 55. COMPETITIVE DASHBOARD
FIGURE 56. COMPETITIVE HEATMAP: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
FIGURE 57. TOP PLAYER POSITIONING, 2021

Executive Summary

According to a new report, titled, 'Ambulatory Polysomnography (Psg) Systems Market,' The ambulatory polysomnography (psg) systems market was valued at $327.00 million in 2021, and is estimated to reach $570.7 million by 2031, growing at a CAGR of 6% from 2022 to 2031.

Portable equipment called ambulatory polysomnography systems is used to diagnose and evaluate sleep problems. These devices are made to be worn by patients as they snooze in their own beds, enabling more precise data collecting and a more natural sleep environment. EEG, EOG, EMG, ECG, respiratory effort and airflow, heart rate, breathing patterns, oxygen levels, and pulse oximetry are just a few of the physiological processes that are typically monitored by ambulatory PSG systems when a person is sleeping. To identify sleep disorders such sleep apnea, narcolepsy, and restless leg syndrome, sleep specialists often analyze the data gathered by ambulatory PSG devices. These devices are especially helpful for patients who have trouble falling asleep in a lab setting because they enable more cosy and natural sleeping settings. Patients can utilize ambulatory PSG devices to track changes in their sleep patterns and symptoms, which makes them ideal for tracking treatment success over time.

The large undiagnosed sleep apnea population is a major factor encouraging the development and uptake of ambulatory equipment. According to estimates, a significant number of persons suffering from sleep apnea goes untreated, preventing them from receiving the essential care to control their disease. This is typically caused by the difficulty and discomfort of having a standard PSG performed in a laboratory setting, as well as a lack of access to sleep laboratories. Ambulatory PSG technology provides a more practical and accessible way for diagnosing sleep apnea and other sleep disorders. Patients may be more inclined to seek a diagnosis and treatment if they may use these devices in the comfort of their own homes. Additionally, compared to conventional home sleep apnea tests (HSATs), ambulatory PSG systems can give sleep specialists more precise data, which can result in more accurate diagnoses and improved treatment outcomes. All things considered, ambulatory PSG devices offer the potential to increase access to sleep disorder diagnosis and treatment, especially for people who are now undiagnosed or unable to access conventional sleep laboratory services.

The market is expected to have a confident outlook due to the rising application of artificial intelligence in PSG systems. Ambulatory PSG sleep studies are becoming a useful diagnostic tool for sleep disorders. Ambulatory PSG facilitates the performance of an overnight polysomnography examination that addresses the patient's comfort in his or her home. It gathers each and every piece of information required for a complete sleep diagnostic investigation. By transferring sleep studies from the laboratory to the house, these devices give sleep clinics the flexibility of wireless and portable PSG systems, allowing them to treat more patients. Artificial intelligence is being used in the field of sleep diagnostics by manufacturers as a response to the trend towards home sleep examinations. This could be viewed as an opportunity for the market for ambulatory polysomnography technologies to expand.

The ambulatory polysomnography systems market has substantial development potential because of the vast undiagnosed population with respect to sleep apnea. According to one of the National Centre for Biotechnology Information's study publications, sleep apnea is a very common illness in the United States that often remains untreated. Because of the advantages afforded by this system over in-lab polysomnography systems, this aspect is expected to boost the market for ambulatory polysomnography (PSG) systems.

The ambulatory polysomnography (PSG) systems market is segmented on the basis of product, application, end-user, and region. On the basis of product, the market is classified into Up to 12 channel PSG systems, Up to 24 channel PSG systems, Up to 32 channel PSG systems, and above 32 channel PSG systems. On the basis of application, the market is classified into obstructive sleep apnea, narcolepsy, chronic insomnia and others. On the basis of end-user, the market is classified into hospitals, sleep laboratories, and home care settings. On the basis of region, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, United Arab Emirates, South Africa, and rest of LAMEA).

The key players profiled in the study include Koninklijke Philips N.V., Natus Medical Incorporated, Nihon Kohden Corporation, Nox Medical, Löwenstein Medical Technology GmbH + Co. KG., neurosoft, Cadwell Industries Inc., SOMNOmedics GmbH, Compumedics Limited, and Neurovirtual / Sleepvirtual.

Key Market Insights

  • Based on product, the up to 24 channel PSG systems sub-segment emerged as the global leader in 2021 and is anticipated to be the fastest growing sub-segment during the forecast period.
  • Based on application, the obstructive sleep apnea sub-segment emerged as the global leader in 2021 and chronic insomnia sub-segment is anticipated to be the fastest growing sub-segment during the forecast period.
  • Based on end-user, the sleep laboratories sub-segment emerged as the global leader in 2021 and is anticipated to be the fastest growing sub-segment during the forecast period.
  • Based on region, the North America market registered the highest market share in 2021 and is projected to maintain its position during the forecast period.

Companies Mentioned

  • Cadwell Industries Inc.
  • Compumedics Limited
  • Compumedics Limited
  • Koninklijke Philips N.V.
  • Löwenstein Medical Technology GmbH + Co. KG.
  • Natus Medical Incorporated
  • neurosoft
  • Nihon Kohden Corporation
  • Nox Medical
  • SOMNOmedics GmbH

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...